A novel echo-parameter supersedes the Society of Thoracic Surgeons risk score in predicting 1-year mortality in patients undergoing transcatheter aortic valve replacement

Objectives We proposed several new echo-parameters (augmented blood pressure) derived from blood pressure and aortic valve gradient measurements and hypothesized that they can accurately predict 1-year mortality post-TAVR.

Background In the era of transcatheter aortic valve replacement (TAVR), predicting post-procedural outcome of patients is one of the most important goals in structural heart research.

Methods Patients in the Mayo Clinic National Cardiovascular Diseases Registry (NCDR)-TAVR database who underwent TAVR between January 1, 2012 and June 30, 2017 were identified to retrieve baseline demographics, STS risk score, ECG, cardiac computed tomography, echocardiographic and mortality data. Augmented blood pressure parameters and valvulo-arterial impedance were evaluated by Cox regression. After logistic model generation, receiver operating curve analysis was used to assess the model performance against STS risk score.

Results The final cohort contained 883 patients with the mean age of 81.3±8.5 years old and 58.2% were male. The mean STS risk score was 8.1±5.1. The median follow-up duration was 353 days and one-year all-cause mortality rates was 13.3%. Multivariate Cox regression showed that augmented SBP and augmented MAP parameters were independent predictors of 1-year mortality (all p<0.0001). A single-parameter model based on augmented MAP1 supersedes STS risk score in predicting 1-year mortality (AUC 0.697 vs. 0.591, p=0.0055).

Conclusion Augmented mean arterial pressure provides a simple but effective approach for clinicians to quickly estimate the clinical outcome of TAVR patients and should be incorporated in the assessment of TAVR candidacy.

Condensed Abstract We proposed and validated a new echo-parameter, augmented mean arterial pressure, in a cohort contains 883 patients who underwent TAVR between January 1, 2012 and June 30, 2017. Multivariate Cox regression showed that augmented MAP parameters was independent predictors of 1-year mortality (all p<0.0001). A single-parameter model based on augmented MAP supersedes STS risk score in predicting 1-year mortality (AUC 0.697 vs. 0.591, p=0.0055). Augmented MAP provides a simple but effective approach for clinicians to quickly estimate the clinical outcome of TAVR patients and should be incorporated in the assessment of TAVR candidacy.